Please login to the form below

Not currently logged in
Email:
Password:

NextWave

This page shows the latest NextWave news and features for those working in and with pharma, biotech and healthcare.

Pfizer enters ADHD market with Quillivant XR launch

Pfizer enters ADHD market with Quillivant XR launch

Pfizer enters ADHD market with Quillivant XR launch. Gained rights last November as part of NextWave acquisition. ... In addition to Quillivant XR, NextWave is developing a chewable tablet formulation of methylphenidate – known as NWP09 - that is due

Latest news

  • Pfizer concludes NextWave acquisition Pfizer concludes NextWave acquisition

    Pfizer concludes NextWave acquisition. Sets company up to compete in the ADHD sector. ... The company had already made a $20m option payment to NextWave earlier this year.

  • Pfizer pays $680m to buy ADHD drug developer NextWave Pfizer pays $680m to buy ADHD drug developer NextWave

    Pfizer pays $680m to buy ADHD drug developer NextWave. Portfolio includes once-daily Quillivant XR. ... In addition to Quillivant XR, NextWave is developing a chewable tablet formulation of methylphenidate - codenamed NWP09 - that is due to be filed for

  • Meeting with resistance

    EU. Clonidine. Nexiclon XR (NextWave Pharmaceuticals). Hypertension. US. Saxagliptin/metformin. Kombiglyze XR (AstraZeneca/Bristol-Myers Squibb).

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Pharma deals during October 2012 Pharma deals during October 2012

    The path to this acquisition started during Q2 2012 when Pfizer entered into an option agreement with NextWave for a fee of $20m to acquire the company. ... 761. NextWave Pharmaceuticals / Pfizer. Acquisition. ADHD and related CNS disorders (lead product

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Kite Pharma names Cynthia Butitta as CFO Kite Pharma names Cynthia Butitta as CFO

    Kite Pharma names Cynthia Butitta as CFO. She helped broker Pfizer’ s takeover of NextWave Pharmaceuticals. ... Butitta was most recently chief financial officer of NextWave Pharmaceuticals and played a key role in the company's acquisition by Pfizer

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics